K Pro
Research agent that answers biomedical questions across Owkin's clinical and molecular datasets and ranks therapeutic targets and gene candidates.
What it does
- Drug discovery
- Data analysis
- Knowledge retrieval
Features 7
- Target prioritizationRanks therapeutic targets and gene candidates using statistical evidence from TCGA and MOSAIC datasets.
- Tractability and drugability assessmentEvaluates target tractability, safety profiles and therapeutic potential using curated databases.
- Patient subgroup characterizationIdentifies distinct populations from multi-omics profiles and clinical outcomes.
- Report generationCreates publication-ready statistical reports for gene or target assessment, biomarker prioritization and patent landscape analysis.
- Biomarker validation across modalitiesTests biomarkers and hypotheses across bulk RNA-seq, single-cell, spatial and clinical data.
- Skills framework and MCP integrationLets users connect their own agents, data and tools through a skills framework and MCP integration.
- CampaignsLaunches parallel campaigns that approach a question from several angles.
Sources
- Pricing
-
FREE Explore and demo on public data / Try for free Book a Demo
- Sold within
-
The K Pro page lists a "FREE" plan ("Explore and demo on public data") beside "Professional" ("Decision-grade analysis on proprietary data") with "Try for free". The FAQ states "You can get started with K Pro’s free version immediately."
- Deployment
-
Official documentation · 13 Oct 2026
Page: 'Deployment SaaS access only SaaS access or deployed on client premise/instance'.
- Modalities
-
Official documentation · 1 Oct 2026
Page: 'ask questions in natural language and get rigorous, publication-ready answers from multimodal patient data'.
- Intended for
-
enterprise: "K Pro, the AI agent for biology...for smarter biopharma decision making" + paid tier offers "Dedicated onboarding & Account Manager" and on-premise deployment; researcher: "Trusted by top biopharma and researchers", with testimonials from named academic researchers (Neuropathologist at APHP, Consultant Haematologist at UCLH, Principal Investigator)
Also from Owkin
-
BiomarkerPlus Data service
Multimodal AI-derived spatial biomarkers, developed with pharmaceutical partners to inform drug discovery and patient stratification.
Something wrong here? Send a correction — quote this product id: owkin-k-pro.